ADMA BIOLOGICS, INC. Professional Fees
ADMA BIOLOGICS, INC. (ADMA) reported Professional Fees of $3.85 thousand for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2012-02-01
- ADMA BIOLOGICS, INC. professional fees for the quarter ending 2011-12-31 was $3.85K, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. professional fees for the quarter ending 2011-09-30 was $3.85K, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. professional fees for the quarter ending 2010-12-31 was $3.85K.
- ADMA BIOLOGICS, INC. professional fees for the quarter ending 2010-09-30 was $3.85K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 64 month | Professional Fees 67 month |
|---|---|---|---|---|
| 2011-12-31 | $3.85K 10-Q · filed 2012-02-01 | $7.70K 10-Q · filed 2012-02-01 | $126.20K 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $3.85K 10-Q · filed 2011-10-28 | $122.35K 10-Q · filed 2011-10-28 | ||
| 2010-12-31 | $3.85K 10-Q · filed 2012-02-01 | $7.70K 10-Q · filed 2012-02-01 | ||
| 2010-09-30 | $3.85K 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |